scholarly journals Hair loss prevention by scalp cooling device in early breast cancer patients: the Poliambulanza experience

2017 ◽  
Vol 28 ◽  
pp. vi35 ◽  
Author(s):  
T. Prochilo ◽  
F. Aroldi ◽  
A. Huscher ◽  
F. Andreis ◽  
E. Zaina ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Hair Loss ◽  
Scalp Cooling ◽  
Breast Cancer Patients ◽  
Loss Prevention ◽  
Cooling Device

Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience

2019 ◽  
Vol 14 (1) ◽  
pp. 66-71 ◽  
Author(s):  
Tiziana Prochilo ◽  
Alessandra Huscher ◽  
Federica Andreis ◽  
Mara Mirandola ◽  
Elisabetta Zaina ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Hair Loss ◽  
Depression Scale ◽  
Hair Follicles ◽  
Common Side Effect ◽  
Scalp Cooling ◽  
Breast Cancer Patients ◽  
Cooling Device ◽  
End Of Treatment

Background: The most effective agents in the treatment of breast cancer have a common side effect, the hair loss. Some studies reported a reduction of hair loss with the use of the scalp cooling device. Indeed, it decreases the drug accumulation in the hair follicles. We report our preliminary experience with a scalp cooling device in reducing chemotherapy-induced alopecia and related distress in breast cancer patients undergoing adjuvant chemotherapy. </P><P> Methods: Hair loss grading and treatment tolerability were evaluated during chemotherapy every 21 days and 3 weeks after the last cycle of chemotherapy via Dean’s scale by patients and operators and a comfort analogic scale by patients. We administered the Hospital Anxiety and Depression Scale questionnaire at the baseline and at the end of treatment to assess the distress related to chemotherapy- induced alopecia. Results: Among the 46 patients identified, 27 accepted the device. The eligible chemotherapy regimens included docetaxel+cyclophosphamide (TC), doxorubicin+cyclophosphamide (AC) and paclitaxel (P) weekly+trastuzumab (T). 24 pts (89%) completed the treatment; 3 pts (11%) treated with AC prematurely interrupted use of the scalp-cooling device due to inefficacy. After the last cycle of chemotherapy, the number of patient who perceived a HL < grade 2 was 16 (59%). The hair retention reported by operators has been higher (78%). 81.5% of patients well tolerated the treatment. Conclusion: In our study, the scalp-cooling device reduced chemotherapy-induced alopecia in taxane- based chemotherapy. Furthermore, it suggests a discordance in hair loss perception between patients and operators.

Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study

2019 ◽  
Vol 26 (7) ◽  
pp. 1296-1301 ◽  
Author(s):  
Tommaso Giarratano ◽  
Simona Frezzini ◽  
Monica Zanocco ◽  
Carlo Alberto Giorgi ◽  
Eleonora Mioranza ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prospective Study ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Scalp Cooling ◽  
Breast Cancer Patients ◽  
Cooling Device ◽  
A Prospective Study

Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy

2020 ◽  
Vol 29 (1) ◽  
pp. 437-443 ◽  
Author(s):  
Shozo Ohsumi ◽  
Sachiko Kiyoto ◽  
Mina Takahashi ◽  
Fumikata Hara ◽  
Seiki Takashima ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Hair Loss ◽  
Scalp Cooling ◽  
Breast Cancer Patients ◽  
Loss Prevention ◽  
Neo Adjuvant Chemotherapy

Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy

2002 ◽  
Vol 10 (7) ◽  
pp. 529-537 ◽  
Author(s):  
Christel Protière ◽  
Katrin Evans ◽  
Jacques Camerlo ◽  
Marie-Pierre d'Ingrado ◽  
Geneviève Macquart-Moulin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Hair Loss ◽  
Cooling System ◽  
Scalp Cooling ◽  
Breast Cancer Patients

P098 Scalp cooling system to prevent hair loss in breast cancer patients receiving chemotherapy

The Breast ◽  
2015 ◽  
Vol 24 ◽  
pp. S59 ◽  
Author(s):  
T. Kinoshita ◽  
K. Tamura ◽  
A. Hashimoto ◽  
T. Ogura ◽  
A. Hironaka ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Hair Loss ◽  
Cooling System ◽  
Scalp Cooling ◽  
Breast Cancer Patients

Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens

The Breast ◽  
2018 ◽  
Vol 41 ◽  
pp. 127-132 ◽  
Author(s):  
Arlene Chan ◽  
Astrid Bauwens ◽  
Sally Pontre ◽  
Sally Jackson ◽  
Frances McGlone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Scalp Cooling ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document